Dr. Fuhrman's NEW G-BOMBS Bars and Limited Edition Peppermint Chocolate Pop'Ems Are Now Available!

Omega-3 fatty acids, DHA and EPA, are crucial for brain health through all stages of life


The long-chain omega-3 fatty acids DHA and EPA are associated with many aspects of brain health. I recommend supplementing with these beneficial fats, since most modern diets are low in DHA and EPA unless fish is consumed regularly, and research has confirmed that vegans tend to have a low omega-3 index.1 DHA is concentrated in the membranes of brain cells; there, DHA provides structure to the membrane and is involved in signaling, connectivity between cells, and neurotransmitter production, among other important actions. EPA and DHA have some common functions and some distinctive ones. DHA is most often associated with brain development, learning and cognition and EPA with mood and behavior, and anti-inflammatory effects.2-5

DHA is necessary for early brain development

DHA is a building block of human brain and eye tissue, and sufficient levels of DHA throughout life are important for vision and learning.2,6  Maternal stores provide the developing baby with the DHA for brain and eye development, and after birth, the DHA is provided by breast milk. There is some evidence that having higher DHA levels, or taking DHA supplements during pregnancy and nursing benefits the child’s cognitive development and intelligence.7,8  Similarly, in randomized controlled trials, infants exposed to DHA-containing formula have similarly shown cognitive improvements at 9 months of age compared to those whose formula did not contain DHA.9

Omega-3 supplementation showed improved learning and attention in childhood and adolescence

Although the time between birth and 2 years represents the phase of the brain’s largest growth, brain development is not complete after age 2; it continues through childhood and into the late twenties.2,10 The majority of omega-3 supplementation trials in children have reported improvements in measures of school performance (such as reading, spelling or learning ability) or behavior.2

One interesting study used functional MRI to view activity in the brains of young boys (8-10 years of age) who took either placebo or a DHA supplement for 8 weeks. The boys who took DHA showed increased functional brain activity during a cognitive task, and their level of activation correlated directly with their blood DHA levels.11 This study suggests that DHA helps the learning process in children. This research has significant implications, since early academic success helps to build confidence and set the stage for future college and career performance. Another study on teens (age 13-15) in the Netherlands found that higher blood omega-3 levels correlated with better scores on cognitive tests.12

Insufficient DHA levels have been implicated in a number of childhood cognitive and developmental disorders such as ADHD, dyslexia, and autism spectrum disorders.13,14  Supplementation with omega-3s, especially in combination with certain omega-6 fatty acids, has been found to improve behavior and ADHD symptoms.15-19 Not enough research has been done on autism spectrum disorders to determine whether omega-3 supplementation would also be helpful for these children.20

DHA and EPA supplementation showed improvements in depression and learning ability in adulthood

In adulthood, omega-3 adequacy helps to maintain optimal brain function, prevent depression and lay the groundwork for a healthy brain later in life. A 6-month study of DHA and EPA supplementation in young adults (18-45 years of age) documented improvements in measures of memory.21 Additionally, 12 weeks of DHA supplementation was found to improve blood flow to the brains of healthy young adults during a cognitive task.22

For women, it is important to note that depletion of DHA stores during pregnancy is thought to be responsible for many cases of postpartum depression.23 Pregnancy and nursing is an important time to maintain adequate DHA not only for the baby, but for the mother too.

Long-chain omega-3 fatty acids can affect the metabolism of mood-related neurotransmitters such as serotonin and dopamine; in addition, the anti-inflammatory effects of DHA and EPA are thought to contribute to reducing depression symptoms.  Higher fish consumption or omega-3 intake is linked to a lower risk of depression. 18,24-26 Omega-3 supplements have also been extensively studied as a treatment for depression.  EPA is primarily responsible for the anti-depressant effects of omega-3 supplements, according to a multiple meta-analyses of trials investigating omega-3 supplements for depression. 27-30

Maintaining adequate levels of DHA and EPA helps to preserving memory and prevent neurodegenerative diseases in older age

Alzheimer’s disease and Parkinson’s disease are the two most common neurodegenerative diseases. Omega-3 fatty acids appear to be useful for preventing these diseases. Low omega-3 intake and low levels of DHA in the blood are associated with age-related cognitive decline and Alzheimer’s disease. 31,32  Also, DHA depletion in certain areas of the brain occurs in Alzheimer’s disease.32 In some studies, low plasma EPA also associated with risk of dementia or cognitive decline.5

More recent studies have investigated brain volume, finding that higher blood omega-3 levels are associated with larger brain volumes in older people, implying that abundant DHA and EPA could help to prevent brain shrinkage with age.10, 33, 34

Beginning supplementation once memory problems have become apparent may have limited utility compared to maintaining adequate levels throughout life. For preventing cognitive decline in older adults, the supplementation trials have shown that older people with mild cognitive impairment may benefit from omega-3 supplementation, whereas those with established Alzheimer’s disease likely do not.32 For example, one study in adults with mild age-related cognitive decline compared DHA and placebo, taken for six months, and administered learning and memory tests before and after. In this study, the DHA group improved their learning and memory scores.35,36  A similar study that tested the effects of DHA on subjects who had already been diagnosed with Alzheimer’s disease did not find any cognitive improvements.37  This research implies that maintaining sufficient omega-3 levels throughout life is an effective preventive measure.

It is known that DHA levels are low in the brains of Parkinson’s patients. Similarly in my clinical experience, I have seen a number of elderly, male vegans who developed Parkinson’s disease; these men were severely deficient in DHA. There have been no clinical trials yet, but animal studies have suggested that DHA and EPA could have a therapeutic effect.5,38,39 Alzheimer’s disease and Parkinson’s disease share the underlying causes of oxidative stress, inflammation and mitochondrial dysfunction. DHA and EPA may be helpful in part by producing anti-inflammatory mediators in the brain.5

Be proactive

No matter what your age, maintaining adequate omega-3 stores is crucial now, and for the later life health and functionality of your brain. A Nutritarian diet provides many nutrients that benefit brain health but is low in pre-formed DHA and EPA since frequent fish consumption is discouraged. Algae-based supplements are preferable to fish, to avoid excess animal protein and pollutants, such as dioxin and mercury, present in fish.  

Conversion of ALA (from walnuts, flax seeds and chia seeds) varies between individuals, and is most often insufficient to provide optimal DHA levels. A study measuring blood DHA and EPA in a vegan population found that 64 percent were insufficient and some were very severely deficient. Those insufficiencies were not related to ALA intake (which was far above recommended intake), suggesting that genetic differences in conversion enzyme activity determines DHA and EPA levels more than ALA intake.  Also in this study, a moderate dose of algae-derived DHA and EPA (254 mg/day) was able to normalize the levels when rechecked four months later.1 This research confirms that high ALA intake in many cases is not enough to assure DHA and EPA adequacy, and suggests that omega-3 supplementation is a useful adjunct to a healthful diet. It just make good sense to either test your blood for omega-3 fatty acid levels to assure that you are sufficient, or take a supplement, or both.  

 

 
References
  1. Sarter B, Kelsey KS, Schwartz TA, Harris WS. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr 2014.
  2. Kuratko CN, Barrett EC, Nelson EB, Salem N, Jr. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review. Nutrients 2013, 5:2777-2810.
  3. Stonehouse W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 2014, 6:2730-2758.
  4. Gomez-Pinilla F, Tyagi E. Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr Opin Clin Nutr Metab Care 2013, 16:726-733.
  5. Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci 2015, 7:52.
  6. Higdon J: Essential Fatty Acids. In An Evidence-Based Approach to Dietary Phytochemicals. New York, NY: Thieme; 2006: 78-99
  7. Ryan AS, Astwood JD, Gautier S, et al. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 2010, 82:305-314.
  8. Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-44.
  9. Drover J, Hoffman DR, Castaneda YS, et al. Three randomized controlled trials of early long-chain polyunsaturated Fatty Acid supplementation on means-end problem solving in 9-month-olds. Child Dev 2009, 80:1376-1384.
  10. Bowman GL, Silbert LC, Howieson D, et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2011.
  11. McNamara RK, Able J, Jandacek R, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 2010, 91:1060-1067.
  12. van der Wurff IS, von Schacky C, Berge K, et al. Association between Blood Omega-3 Index and Cognition in Typically Developing Dutch Adolescents. Nutrients 2016, 8.
  13. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr 2010, 169:149-164.
  14. Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995, 62:761-768.
  15. Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids 2008, 78:311-326.
  16. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr 2007, 28:82-91.<
  17. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders. J Atten Disord 2010, 14:232-246.
  18. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 2007, 12:207-227.
  19. Bloch MH, Qawasmi A. Omega-3 Fatty Acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011, 50:991-1000.
  20. James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011:CD007992.
  21. Stonehouse W, Conlon CA, Podd J, et al. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J Clin Nutr 2013, 97:1134-1143.
  22. Jackson PA, Reay JL, Scholey AB, Kennedy DO. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. Br J Nutr 2012, 107:1093-1098.
  23. Ramakrishnan U, Imhoff-Kunsch B, DiGirolamo AM. Role of docosahexaenoic acid in maternal and child mental health. Am J Clin Nutr 2009, 89:958S-962S.
  24. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 2015, 29:2207-2222.
  25. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 2008, 9:57-64.
  26. Grosso G, Galvano F, Marventano S, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev 2014, 2014:313570.
  27. Grosso G, Pajak A, Marventano S, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014, 9:e96905.=
  28. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009, 28:525-542.
  29. Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011, 72:1577-1584.
  30. Mocking RJ, Harmsen I, Assies J, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016, 6:e756.
  31. Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 2010, 7:190-196.
  32. Cederholm T, Salem N, Jr., Palmblad J. omega-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr 2013, 4:672-676.
  33. Pottala JV, Yaffe K, Robinson JG, et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 2014, 82:435-442.
  34. Tan ZS, Harris WS, Beiser AS, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78:658-664.
  35. Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010.
  36. DHA Improves Memory and Cognitive Function in Older Adults, Study Suggests. In ScienceDaily, 2010 [http://www.sciencedaily.com/releases/2010/11/101108151346.htm]
  37. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010, 304:1903-1911.
  38. Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 2007, 77:287-293.
  39. Bousquet M, Saint-Pierre M, Julien C, et al. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 2008, 22:1213-1225